Tuesday 12 March 2013

Inspection of speciality compounding pharmacies

Following the fungal meningitis outbreak last fall that was linked to contaminated sterile drugs (NECC), the FDA has launched an inspection campaign of large specialty pharmacies. The inspections mid February and will continue over the next two months, covering about 30 facilities.

For further information see: Washington Post

Posted by Tim Sandle
Posted by at
Labels:

1 comment:

  1. Anonymous3 April 2013 at 16:06

    note that the pharma industry lobbied to prevent federal regulation of the growing compounding-pharmacy industry, and thereafter the worst happened -

    ReplyDelete

Pharmaceutical Microbiology Resources

Subscribe to: Post Comments (Atom)

Special offers